Ameriprise Financial Inc Arvinas, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 97,008 shares of ARVN stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

97,008

Previous 94,658 2.48%

Holding current value

$1.85 Million

Previous $2.52 Million 5.16%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.66 - $32.73 $55,601 - $76,915	2,350 Added 2.48%	97,008 $2.39 Million
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $495,681 - $818,706	20,265 Added 27.24%	94,658 $2.52 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $15,206 - $21,865	418 Added 0.57%	74,393 $3.07 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $215,546 - $642,992	15,190 Added 25.84%	73,975 $3.04 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $91,522 - $131,458	4,660 Added 8.61%	58,785 $1.15 Million
Q2 2023 Aug 14, 2023	SELL	$21.73 - $31.43 $304,350 - $440,208	-14,006 Reduced 20.56%	54,125 $1.34 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $555,739 - $791,849	21,252 Added 45.33%	68,131 $1.86 Million
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $134,912 - $237,832	-4,155 Reduced 8.14%	46,879 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $224,716 - $311,232	5,367 Added 11.75%	51,034 $2.27 Million
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $207,309 - $427,399	5,757 Added 14.42%	45,667 $1.92 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $273,505 - $370,164	4,538 Added 12.83%	39,910 $2.69 Million
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $362,899 - $530,213	-5,511 Reduced 13.48%	35,372 $2.91 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $245,293 - $361,472	3,351 Added 8.93%	40,883 $3.36 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $192,714 - $268,620	3,188 Added 9.28%	37,532 $2.89 Million
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $461,737 - $725,020	-7,935 Reduced 18.77%	34,344 $2.27 Million
Q4 2020 Feb 12, 2021	BUY	$20.19 - $84.93 $34,767 - $146,249	1,722 Added 4.25%	42,279 $3.59 Million
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $458,926 - $725,419	19,962 Added 96.93%	40,557 $957,000
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $615,378 - $1.17 Million	20,595 New	20,595 $691,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Arvinas, Inc. Transaction History